e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Novel biomarkers and old parameters in clinical management of lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nutritional status and admission risk in Duchenne muscular dystrophy (DMD)
A. Reddy, C. E. Weekes, H. Ahmed, N. Hart (London, United Kingdom)
Source:
Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Session:
Novel biomarkers and old parameters in clinical management of lung diseases
Session type:
Poster Discussion
Number:
422
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Reddy, C. E. Weekes, H. Ahmed, N. Hart (London, United Kingdom). Nutritional status and admission risk in Duchenne muscular dystrophy (DMD). Eur Respir J 2013; 42: Suppl. 57, 422
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Flexible bronchoscopy in children with neuromuscular disease and acute hypoxemic respiratory failure requiring noninvasive ventilation
Perinatal outcomes in pregnant women with asthma
Early introduction of non invasive ventilation (NIV) in patients with systemic lupus erythematosus (SLE) and diaphragmatic weakness
Related content which might interest you:
Effects of idebenone on pulmonary morbidity in Duchenne muscular dystrophy (DMD)
Source: International Congress 2017 – New ideas for the management of chronic lung diseases
Year: 2017
Observation cohort study of cause of death in patients with Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012
Evaluating the effect of long-term idebenone treatment on respiratory morbidity in patients with Duchenne muscular dystrophy (DMD)
Source: International Congress 2019 – Rare and ultra-rare diseases and the lungs: updates and new perspectives
Year: 2019
Home-based versus hospital monitoring of respiratory function changes in Duchenne muscular dystrophy (DMD)
Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction
Year: 2018
Gastrointestinal dysfunction in ventilated patients with Duchenne muscular dystrophy
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012
Evolution of respiratory function in Duchenne muscular dystrophy from childhood to adulthood
Source: Eur Respir J, 51 (2) 1701418; 10.1183/13993003.01418-2017
Year: 2018
Chronic respiratory failure in myotonic dystrophy type 1 (DM1): Incidence & risk factors
Source: International Congress 2017 – Clinical and physiological challenges in noninvasive ventilation
Year: 2017
Challenge already established: Identification of risk factors for early need for ventilatory support in Duchenne muscular dystrophy
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
Respiratory kinematics in Duchenne muscular dystrophy (DMD)
Source: Eur Respir J 2007; 30: Suppl. 51, 376s
Year: 2007
Sleep in patients with Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA): is there a difference?
Source: Eur Respir J 2001; 18: Suppl. 33, 88s
Year: 2001
Respiratory muscle testing: a valuable tool for young patients with Duchenne muscular dystrophy
Source: Eur Respir J 2006; 28: Suppl. 50, 357s
Year: 2006
Meta-analysis of two clinical trials: Slowing respiratory decline in Duchenne muscular dystrophy (DMD)
Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology
Year: 2017
Ventilatory assistance in patients with Duchenne muscular dystrophy
Source: Eur Respir J 2006; 28: 468-469
Year: 2006
Implication of regular pulmonary function evaluation in Duchenne muscular dystrophy
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020
Assessment of diaphragm thickness variations by ultrasonography in patients with Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012
Resistance in patients with muscular dystrophy
Source: Eur Respir J 2006; 28: Suppl. 50, 861s
Year: 2006
Inefficient cough in Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Physiological monitoring during sleep and in neuromuscular disease in children
Year: 2012
Severe metabolic acidosis in chronically ventilated Duchenne muscular dystrophy patients
Source: Annual Congress 2011 - Mechanical ventilation and weaning
Year: 2011
Respiratory function, scoliosis and arthrodesis in Duchenne muscular dystrophy
Source: International Congress 2015 – Respiratory physiology in children: technical and clinical aspects
Year: 2015
Introduction of domiciliary mechanical insufflation-exsufflation can reduce the incidence of crisis admissions in patients with Duchenne muscular dystrophy (DMD)
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept